Pitfalls in Estimating the Influence of Overall Treatment Time on Local Tumor Control

REFERENCES

• Withers HR. The four R's of radiotherapy. In: Lett JT, Adler H, ed. Advances in radiation biology, 5th ed. New York: Academic Press, 1975: 241–247.
   Google Scholar
• Steel GG. Growth kinetics of tumours. Oxford: Clarendon Press, 1977.
   Google Scholar
• Hermens AF, Barendsen GW. Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after x-irradiation. Eur J Cancer 1969; 5: 173–8.
   PubMed Web of Science ®Google Scholar
• Suit HD, Howes AE, Hunter N. Dependence of response of a C3H mammary carcinoma to fractionated irradiation on frac-tion number and intertreatment interval. Radiat Res 1997; 72: 440–54.
   Google Scholar
• Trott KR, Kummermehr J. What is known about tumor proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol 1985; 3: 1–9.
   PubMed Web of Science ®Google Scholar
• Amdur RJ, Parsons JT, Mendenhall WM, Million RR, Cas-sisi NJ. Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1989; 17: 279–85.
   Google Scholar
• Barton MB, Keane TJ, Gadalla T, Maki E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 23: 137–43.
   PubMed Web of Science ®Google Scholar
• Bataini JP, Asselain B, Jaulerry Ch, et al. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors. Radiother Oncol 1989; 14: 265–77.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Johansen LV, Overgaard J, Thames HD. Clini-cal radiobiology of squamous cell carcinoma of the orophar-ynx. Int J Radiat Oncol Biol Phys 1991; 20: 1197–206.
   PubMed Web of Science ®Google Scholar
• Budihna M, 'Skrk J, 'Smid L, Furlan L. Tumor cell repopula-tion in the rest interval of split-course radiation treatment. Strahlenther Onkol 1980; 156: 402–8.
   Google Scholar
• Duncan W, MacDougall RH, Kerr GR, Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol 1996; 41: 203–7.
   PubMedGoogle Scholar
• Hendry JH, Roberts SA, Slevin NJ, Keane TJ, Barton MB, ;kgren-Cronqvist A. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother Oncol 1994; 31: 14–22.
   Google Scholar
• Herrmann Th, Jakubek A, Trott KR. The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck. Strahlenther Onkol 1994; 170: 545–9.
   Google Scholar
• Keane TJ, Fyles A, O'Sullivan B, Barton M, Maki E, Simm J. The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervix. Semin Radiat Oncol 1992; 2: 26–8.
   Google Scholar
• Maciejewski B, Preuss-Bayer G, Trott K-R. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int .1- Radiat Oncol Biol Phys 1983; 9: 321–8.
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Withers HR, Taylor JMG, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int .1- Radiat Oncol Biol Phys 1989; 16: 831–43.
   PubMed Web of Science ®Google Scholar
• Nishmura Y, Nagata Y, Okajima K, et al. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control. Radiother Oncol 1996; 40: 225–32.
   PubMedGoogle Scholar
• Overgaard J, Hjelm-Hansen M, Vendelbo Johansen L, Ander-son AP. Comparison of conventional and split-course radio-therapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988; 27: 147–52.
   PubMed Web of Science ®Google Scholar
• Parsons JT, Bova FJ, Million RR. A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int .1- Radiat Oncol Biol Phys 1980; 6: 1645–52.
   Google Scholar
• Rezvani M, Fowler JF, Hopewell JW, Alcock CJ. Sensitivity of human squamous cell carcinoma of the larynx to fraction-ated radiotherapy. Br J Radiol 1993; 66: 245–55.
   PubMed Web of Science ®Google Scholar
• Roberts SA, Hendry JH, Brewster AE, Slevin NJ. The influ-ence of radiotherapy treatment time on the control of laryn-geal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor. Br J Radiol 1994; 67: 790–4.
   PubMed Web of Science ®Google Scholar
• Robertson AG, Robertson C, Boyle P, Symonds RP, Whel-don TE. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993; 29A: 501–10.
   Google Scholar
• Robertson C, Robertson AG, Hendry JH, et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of car-cinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 1998; 40: 319–29.
   PubMed Web of Science ®Google Scholar
• Skladowski K, Law MG, Maciejewski B, Steel GG. Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. Radiother Oncol 1994; 30: 109–20.
   PubMed Web of Science ®Google Scholar
• Slevin NJ, Hendry JH, Roberts SA, /kgren-Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using Radiother-apy. Radiother Oncol 1992; 24: 215–20.
   Google Scholar
• Spanos WJ, Shukovsky LJ, Fletcher GH. Time, dose, and tumor volume relationships in irradiation of squamous cell carcinomas of the base of the tongue. Cancer 1976; 37: 2591–9.
   Google Scholar
• Taylor JMG, Withers HR, Mendenhall WM. Dose-time con-siderations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 1990; 17: 95–102.
   Google Scholar
• Van den Bogaert W, Van der Leest A, Rijnders A, Delaere P, Thames H, van der Scheuren E. Does tumor control decrease by prolonging overall treatment time or interrupting treat-ment in laryngeal cancer? Radiother Oncol 1995; 36: 177–82.
   PubMed Web of Science ®Google Scholar
• Vikram B, Mishra UB, Strong EW, Manolatos S. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys 1985; 11: 1455–9.
   PubMed Web of Science ®Google Scholar
• Wang CC, Efird JT. Does prolonged treatment course ad-versely affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys 1994; 29: 657–60.
   PubMedGoogle Scholar
• Withers HR, Peters LJ, Taylor JMG, et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995; 33: 549–62.
   PubMed Web of Science ®Google Scholar
• Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46.
   Google Scholar
• Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radio-ther Oncol 1997; 44: 123–36.
   PubMed Web of Science ®Google Scholar
• Porter EH. The statistics of dose/cure relationships for irradi-ated tumours. Br J Radiol 1980; 53: 210–27.
   PubMedGoogle Scholar
• Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol 1990; 19: 219–35.
   Google Scholar
• Hendry JH. Treatment acceleration in radiotherapy: the rela-tive time factors and dose-response slopes for tumours and normal tissues. Radiother Oncol 1992; 25: 308–12.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Lindstrom MJ. Loss of local control with prolon-gation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23: 457–67.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Tanner MA, Bataini JP, Asselain B, Bernier J, Lave C. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 1990; 19: 237–44.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Thames HD. Clinical evidence for tumor clono-gen regeneration: interpretations of the data. Radiother Oncol 1991; 22: 161–6.
   PubMed Web of Science ®Google Scholar
• Brenner D. Accelerated repopulation during radiotherapy: quantitative evidence for delayed onset. Radiat Oncol Invest 1993; 1: 167–72.
   Google Scholar
• Dubben H-H. Local control, TCD50 and dose-time prescrip-tion habits in radiotherapy of head and neck tumours. Radio-ther Oncol 1994; 32: 197–200.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Thames HD. Overall treatment time and tumor control dose for head and neck tumors: the dog leg revisited. Radiother Oncol 1992; 25: 143–4.
   PubMed Web of Science ®Google Scholar
• Dubben H-H. No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours. Radio-ther Oncol 1992; 25: 142–3.
   PubMedGoogle Scholar
• Thames HD, Bentzen SM. Time factor for tonsillar car-cinoma. Int J Radiat Oncol Biol Phys 1995; 33: 755–8.
   PubMedGoogle Scholar
• Tucker SL, Taylor JMG. Improved models of tumour cure. Int J Radiat Biol 1996; 70: 539–53.
   PubMed Web of Science ®Google Scholar
• Tucker SL, Thames HD, Taylor JMG. How well is the probability of tumour cure after fractionated irradiation de-scribed by Poisson statistics? Radiat Res 1990; 124: 273–82.
   Google Scholar
• Maiwald C, Liertz-Petersen C, Schreiber A, Arps H, Bau-mann M. Dynamisch fraktionierte Strahlentherapie zweier menschlicher Plattenepithelkarzinome auf Nacktmdusen. Exp Strahlenther Klin Strahlenbiol 1997; 6: 156–9.
   Google Scholar
• Dubben H-H, Beck-Bornholdt H-P. Influence of the timing of a concomitant boost during fractionated irradiation of rat rhabdomyosarcoma R1H. Acta Oncol 1993; 32: 79–82.
   PubMed Web of Science ®Google Scholar
• Quaester S, Dubben H-H, Krii11 A, Beck-Bornholdt H-P. Strahlentherapie des R1H-tumors: Einfluss des Zeitpunktes eines Boosts. Exp Strahlenther Klin Strahlenbiol 1997; 6: 156–9.
   Google Scholar